
World-first trial to provide hearing for children with rare type of genetic hearing loss launches in Cambridge
Children who are born with hearing loss due to the genetic condition…

Outstanding Clinical Investigator Award to Professor Sadaf Farooqi
Congratulations to our Co-director, Professor Sadaf Farooqi,…

UK-wide COVID-19 vaccine study reports long-term third dose booster protection
Third dose COVID-19 booster vaccines offer lasting protection…

Obesity accelerates loss of COVID-19 vaccination immunity, study finds.
A new study led by scientists at the Universities of Cambridge…

Volunteers needed for new needle-free coronavirus vaccine at CRF
Recruitment is underway in Cambridge for volunteers to take part…

NICE recommends Cambridge-developed ‘artificial pancreas’ for use on NHS for management of type 1 diabetes
The artificial pancreas for type 1 diabetes developed in Cambridge and supported in trials by the NIHR Cambridge CRF could soon be approved for use in the NHS.

UKCRF Network awarded £2.4 million in public funding to support the delivery of early phase research studies
The UK Clinical Research Facility Network (UKCRF Network), hosted…

New Year Honour for pioneering research
Congratulations to our NIHR Cambridge CRF Director, Professor…

COV-BOOST national vaccination trial at Addenbrooke’s
A team from Cambridge is inviting individuals aged 18 to 30 years…